Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys

Transplantation

Volumn 72, Issue 6, 2001, Pages 1128-1137

  Hausen, Bernard ^a,e   Klupp, Jochen ^a   Christians, Uwe ^a,b   Higgins, John P ^a   Baumgartner, Roxanne E ^c   Hook, Laurie E ^a   Friedrich, Stuart ^d   Celnicker, Abbie ^c   Morris, Randall E ^a,e  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

^d PFIZER INC   (United States)

^e STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CALCINEURIN INHIBITOR; CD86 ANTIGEN; CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; PREDNISONE; STEROID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL;

EID: 0035959983     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200109270-00025     Document Type: Article

References (35)

1. Improved graft survival after renal transplantation in the United States, 1988 to 1996
2. Factors influencing long-term graft loss
3. Effect of immunosuppressive therapy on graft half-life projections
4. The impact of an acute rejection episode on long-term renal allograft survival (t1/2)
5. Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection
6. Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells
7. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation
8. CD28 costimulation prevents cell death during primary T cell activation
9. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
10. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
11. The CD40 pathway in allograft rejection, acceptance, and tolerance
12. Blocking of costimulation prevents kidney graft rejection in rhesus monkeys
13. Blocking of costimulatory pathways using monoclonal antibodies as a new strategy to prevent transplant rejection in a non-human primate model
14. Primate allotransplantation using costimmulation blockade
15. The B7 and CD28 receptor families
16. CD28/B7 system of T cell costimulation
17. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule
18. Effect of CTLA-4 chimeric protein on rat autoimmune antiglomerular basement membrane glomerulonephritis
19. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade
20. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies
21. Transplantation tolerance: A look at the nonhuman primate literature in the light of modern tolerance theories
22. Specific acceptance of cardiac allografts after treatment with antibodies to CD80 and CD86 in mice
23. Prevention of renal allograft rejection in primates by blocking the B7/CD28 pathway
24. Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: Immunosuppressants
25. The Banff 97 working classification of renal allograft pathology
26. Long-term rejection free survival in primate allotransplantation with costimmulation blockade
27. Costimmulation blockade in nonhuman primate renal allotransplantation
28. Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients
29. Induction of peripheral tolerance in vivo requires CTLA-4 engagement
30. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
31. Intracellular trafficking of CTLA-4 focal localization towards sites of TCR engagement
32. Humanized anti-B7.1 and anti-B7.2 antibodies prevent antigen specific induction of immunity in nonhuman primates immunized with tetanus toxoid and mumps virus vaccine
33. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
34. The future of organ and tissue transplantation: Can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection?
35. Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment